logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure GPS-3. Last month prevalence of cannabis among the age group of 15 to 24 years, measured by national surveys

Notes:

Data are from the most recent national surveys available in each country.

Some countries use a slightly different age range to the EMCDDA standard age range for young adults. Variations in age ranges may slighly influence disparities between countries.

Belgium: 2004; 15-24 y. n=

Bulgaria: 2005; 18-24 y. n=173

Czech Republic: 2004; 18-24 y. n=586

Denmark: 2005; 16-24 y. n=1434

Germany: 2003; 18-24 y. n=1891

Estonia: 2003; 15-24 y. n=329

Ireland: 2002/03; 15-24 y. n=

Greece: 2004; 15-24 y. n=1785

Spain: 2005-06; 15-24 y. n=8188

France: 2005; 15-24 y. n=4662

Italy: 2005; 15-24 y. n=9006

Cyprus: 2006; 15-24 y. n=969

Latvia: 2003; 15-24 y. n=

Lithuania: 2004; 15-24 y. N=923

Luxembourg: 1998; 15-24 y. n=

Hungary: 2003; 18-24 y. n=943

Netherlands: 2005; 15-24 y. n=

Austria: 2004; 15-24 y. n=959

Poland: 2002; 16-24 y. n=

Portugal: 2001; 15-24 y. n=3099

Slovakia: 2004; 15-24 y. n=307

Finland: 2004; 15-24 y. n=494

Sweden: 2006; 16-24 y. n=7014

UK (E&W): 2005/06; 16-24 y. n=5892

Norway: 2004; 15-24 y. n=645

Links:

SB2006: Figure GPS-3.

See also Table GPS-0.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Reitox national reports 2006, taken from population surveys, reports or scientific articles

Page last updated: Thursday, 15 November 2007